Where does K.U. Leuven Research & Development rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), K.U. Leuven Research & Development ranks #41,302 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does K.U. Leuven Research & Development hold?

K.U. Leuven Research & Development holds 6 US utility patents granted between 2016 and 2021, spanning 10 technology areas.

What is K.U. Leuven Research & Development's Innovation Score?

K.U. Leuven Research & Development has an Innovation Score of 26.6 out of 100 (21st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is K.U. Leuven Research & Development's patent grant rate increasing or decreasing?

K.U. Leuven Research & Development's recent grant velocity is -80% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for K.U. Leuven Research & Development's patents?

K.U. Leuven Research & Development's patents average 14.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the K.U. Leuven Research & Development patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

K.U. Leuven Research & Development

Q: What technology areas does K.U. Leuven Research & Development focus on?

K.U. Leuven Research & Development's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 10 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, K.u. ranks #41,302 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 10 technology areas.

#41,302
of 49,997 US assignees by volume: 21st percentile
by Innovation Score (26.6/100): 14.5
avg claims per patent: -80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R41302 · Foreign Corporation #41,302 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #41,302/49,997
PHOTO-FINISH Juventas Innovations
CPC-FOCUS A61P · 10 areas
INNOV-THIN 26.6/100
CLAIMS-RICH 14.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -80% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Juventas Innovations, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
K U Leuven Research… · this assignee

27
3D Lighting… · lowest

7

What this shows K.u.'s Innovation Score is 26.6/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where K.u.'s grants concentrate

K.U. Leuven Research & Development is a focused PatentsView assignee: 10 CPC subclasses with 83.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2018. By volume, K.u. sits between Juventas Innovations, LLC and Kabushiki Kaisha Kinki.

Juventas Innovati…

6
K-marine

6
K-rain Manufactur…

6
K J Manufacturing

6
K1 Medical

6
K2 Software

6
Kaboodl

6
Kinki

6
K U Leuven Resear… ◀

6

What this shows K.U. holds 6 patents at rank #41,134, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near KU

By rank, the assignees closest to #41,134 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in KU's primary technology class.

K.u.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 21st percentile higher than 21% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

K.U. Leuven Research & Development patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	66.7%
2018	1	16.7%
2021	1	16.7%

Which technologies does K.U. Leuven Research & Development patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

C07D - Heterocyclic Compounds 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C07K - Peptides 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#41,302

of 49,997 tracked assignees

Innovation Score

26.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

K.U. Leuven Research & Development's patent record in context - here's where to go next.

K.U. Leuven Research & Development's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 83.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #41,302 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare K.U. Leuven Research & Development against Juventas Innovations, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.